arBtrage CAPITALIZING MARKETS checking… Sign in

Hemab Therapeutics Holdings, Inc.

COAG Health Care Biotechnology: Biological Products (No Diagnostic Substances)
$25.30
▼ -0.4% Today
as of Jun 7, 07:11 ET
Last 30 days -25.59% May 01 → Jun 05
$24.28 $26.89 $29.50 $32.11 $34.72 May 01 May 08 May 15 May 21 May 29 Jun 05
Open
$25.62
High
$26.15
Low
$24.50
Volume
$183,497
Avg Vol
$370,972
Mkt Cap
$1.3B
P/E (TTM)
Beta
52w High
$36.61
52w Low
$23.00
Div Yield
Shares Out

Overview

52-week range
$23
$37
17% of range
Avg surprise (last 0)
Avg reaction (last 1)
-0.6%
0% positive

Earnings trends

EPS — actual vs estimate Actual Estimate
$-23.98$-22.03$-20.08$-18.13$-16.18 Actual $-16.18Actual $-23.98 MarMar/2026
Revenue vs Net Income Revenue Net income
$-23M$-21M$-19M$-18M$-16M Mar 25Mar 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Thu May 21, 2026Mar/2026 $-23.98 -0.6% earnings
Mon Mar 31, 2025Mar 2025 $-16.18 financials

Financials

Income statement (quarterly)

MetricMar 2026Dec 2025Mar 2025
Revenue
Cost of revenue
Gross profit
Operating income$-24M$-17M
Net income$-23M$-15M
EPS (diluted)$-23.98$-16.18

Balance sheet (quarterly)

MetricMar 2026Dec 2025Mar 2025
Cash & equivalents$50M$88M
Inventory
Total current assets$169M$193M
Total assets$175M$195M
Long-term debt
Total liabilities$14M$11M
Total equity$-199M$-177M

Implied volatility — last 90 days

No IV snapshots yet for COAG.

IV is captured twice daily (9:15 AM & 4:30 PM ET) for tickers with upcoming earnings. Comes online automatically once the next options refresh runs.

Sector peers